Authors


Penny Hylton, PhD

Latest:

Quality Agreements for Contract Manufacturers

A well-constructed quality agreement can be an important tool to enable effective collaboration between owner and CMO.


Martin Wisher

Latest:

Vector Manufacturing and Testing for Gene and Cell Therapy Applications

The authors offer insight into cell therapy manufacturing, vector production, and the safety aspects of testing for characterization.


Rüdiger Heidemann, PhD

Latest:

Single-Use Bioreactors for the Rapid Production of Preclinical and Clinical Biopharmaceuticals

Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.


Paul Wu, PhD

Latest:

Single-Use Bioreactors for the Rapid Production of Preclinical and Clinical Biopharmaceuticals

Fed-batch processes were scaled up from traditional bench-scale bioreactors to large-scale single-use systems.


Renu Jain

Latest:

Setting Standards for Biotech Therapeutics in India

The authors take a look at the past and future impact of the Indian Pharmacopoeia Commission.


Michael J. Shea

Latest:

Assessing a Risk Management Program

Program review can help quality risk management live up to the promise of ICH Q9.



Jeff Fleming

Latest:

Continued Process Verification for Biopharma Manufacturing

The authors discuss complications of implementing continued process verification and provide recommended approaches.



Marilyn E. Morris

Latest:

Bolstering Graduate Education and Research Programs

AAPS supports graduate-level programs impacted by cutbacks in funding and resources.


Andy Fry

Latest:

A Review of the Challenges of Delivering Macromolecule Biologicals

Selecting a delivery method early on may be beneficial.



Sal Giglia

Latest:

New Binary Gas Integrity Test Improves Membrane Quality Assurance

The authors developed a test for defects in filter membranes.


Bernard N. Violand

Latest:

Addressing the Challenges in Downstream Processing Today and Tomorrow

Newer classes of biotherapies will require innovations in processing technology.


Sandrine Dessoy

Latest:

Disposable Bioreactors for Viral Vaccine Production: Challenges and Opportunities

Switching to single-use bioreactors can have financial and performance benefits.


Agnes Shanley

Latest:

Track-and-Trace Progress Benefits Supply-Chain Security Efforts

The industry has made great strides in implementing serialization technologies, while technology developers are enabling more open access to real-time transportation data.



Rory Mullen, senior vice-president and West Coast director, IDA Ireland

Latest:

Ireland: The Gateway to Biopharma's Future

Despite recent changes in corporate tax law, Ireland remains a valuable and attractive partner in the development and manufacture of biopharmaceuticals.


Jean-François Chaubard

Latest:

Disposable Bioreactors for Viral Vaccine Production: Challenges and Opportunities

Switching to single-use bioreactors can have financial and performance benefits.


Fedra Pavlou

Latest:

Trends in Prefills

An interview with Oskar Gold, vice-president, key account management and corporate marketing, at Vetter.


Ryan R. Manning

Latest:

Review of Orthogonal Methods to SEC for Quantitation and Characterization of Protein Aggregates

The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.


Glenn A. Wilson

Latest:

Review of Orthogonal Methods to SEC for Quantitation and Characterization of Protein Aggregates

The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.


Mark Cornell Manning

Latest:

Review of Orthogonal Methods to SEC for Quantitation and Characterization of Protein Aggregates

The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.


Charles S. Henry

Latest:

Review of Orthogonal Methods to SEC for Quantitation and Characterization of Protein Aggregates

The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.


Ryan E. Holcomb

Latest:

Review of Orthogonal Methods to SEC for Quantitation and Characterization of Protein Aggregates

The use of orthogonal methods to SEC is discussed and examples are presented showing how analytical ultracentrifugation, AF4, and SEC compare in aggregate quantitation.


Jan Paul Zonnenberg

Latest:

A Next Generation of Quality Management

The author proposes a quality management system that uses the power of executive management to promote a positive quality culture.


Scott Probst

Latest:

Challenging the Cleanroom Paradigm for Biopharmaceutical Manufacturing of Bulk Drug Substances

The authors re-examine environmental controls in the context of technical advances in manufacturing.


Emile Nuwaysir

Latest:

Industrialized Production of Human iPSC-Derived Cardiomyocytes for Use in Drug Discovery and Toxicity Testing

The authors describe an industrialized process for the manufacture of iPSC-derived human cardiomyocytes.


James R. Darnell, Jr.

Latest:

Time to Revisit Supplier Quality Management

Best practices to strengthen supplier quality management.


Jerry Dong

Latest:

The Quality Product Steward Model: The Genentech Approach

A successful QPS acts as a single point of contact for consistent product quality oversight.

© 2025 MJH Life Sciences

All rights reserved.